Connection

Janardan Pandey to Middle Aged

Back to Details
This is a "connection" page, showing publications Janardan Pandey has written about Middle Aged.
Janardan Pandey
Connection Strength
0.762
Middle Aged
  1. An Ig ? Marker Genotype Is a Strong Risk Factor for Alzheimer Disease, Independent of Apolipoprotein E e4 Genotype. J Immunol. 2020 09 01; 205(5):1318-1322.
    View in: PubMed
    Score: 0.050
  2. Genetic markers of immunoglobulin G and immunity to cytomegalovirus in patients with breast cancer. Cell Immunol. 2017 02; 312:67-70.
    View in: PubMed
    Score: 0.039
  3. Immunoglobulin G genotypes and the risk of schizophrenia. Hum Genet. 2016 10; 135(10):1175-9.
    View in: PubMed
    Score: 0.038
  4. Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma. Neuro Oncol. 2015 May; 17(5):678-84.
    View in: PubMed
    Score: 0.034
  5. Genetic variants of immunoglobulin ? and ? chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer. Clin Exp Immunol. 2014 Apr; 176(1):78-83.
    View in: PubMed
    Score: 0.032
  6. Suggestive evidence that Fc variants of IgG2 and Fc?RIIa loci interact to contribute to the risk of prostate cancer. Hum Immunol. 2013 Dec; 74(12):1656-8.
    View in: PubMed
    Score: 0.031
  7. IgG and Fc?R genotypes and humoral immunity to mucin 1 in prostate cancer. Hum Immunol. 2013 Aug; 74(8):1030-3.
    View in: PubMed
    Score: 0.030
  8. A genetic variant of Fc?RIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer. Immunogenetics. 2013 Feb; 65(2):91-6.
    View in: PubMed
    Score: 0.029
  9. Humoral immunity to cytomegalovirus and chronic graft-versus-host disease. Viral Immunol. 2012 Aug; 25(4):338-40.
    View in: PubMed
    Score: 0.029
  10. Epistatic interactions between Fc (GM) and Fc?R genes and the host control of human immunodeficiency virus replication. Hum Immunol. 2012 Mar; 73(3):263-6.
    View in: PubMed
    Score: 0.028
  11. Genetic variation at immunoglobulin kappa locus is associated with hepatitis C-treatment-induced viral clearance in African Americans. Hum Immunol. 2011 Aug; 72(8):667-70.
    View in: PubMed
    Score: 0.026
  12. Genetic regulation of antibody responses to human epidermal growth factor receptor 2 in breast cancer. Hum Immunol. 2010 Nov; 71(11):1124-7.
    View in: PubMed
    Score: 0.025
  13. Immunoglobulin GM 3 23 5,13,14 phenotype is strongly associated with IgG1 antibody responses to Plasmodium vivax vaccine candidate antigens PvMSP1-19 and PvAMA-1. Malar J. 2010 Aug 09; 9:229.
    View in: PubMed
    Score: 0.025
  14. A genetic variant of immunoglobulin gamma2 is strongly associated with immunity to mucin 1 in patients with breast cancer. Cancer Immunol Immunother. 2009 Dec; 58(12):2025-9.
    View in: PubMed
    Score: 0.023
  15. Immunoglobulin allotypes influence antibody responses to mucin 1 in patients with gastric cancer. Cancer Res. 2008 Jun 01; 68(11):4442-6.
    View in: PubMed
    Score: 0.022
  16. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum. 2005 Apr; 52(4):1148-59.
    View in: PubMed
    Score: 0.017
  17. Immunoglobulin KM and GM gene polymorphisms modify the clinical presentation of primary Sj?gren's syndrome. J Rheumatol. 2004 Nov; 31(11):2175-80.
    View in: PubMed
    Score: 0.017
  18. Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus. J Virol. 2004 May; 78(9):4561-5.
    View in: PubMed
    Score: 0.016
  19. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis. 2004 Jan; 63(1):91-4.
    View in: PubMed
    Score: 0.016
  20. Epistatic effects of genes encoding immunoglobulin GM allotypes and interleukin-6 on the production of autoantibodies to 60- and 65-kDa heat-shock proteins. Genes Immun. 2004 Jan; 5(1):68-71.
    View in: PubMed
    Score: 0.016
  21. CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus. 2004; 13(10):784-91.
    View in: PubMed
    Score: 0.016
  22. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol. 1999 Nov; 26(11):705-9.
    View in: PubMed
    Score: 0.012
  23. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial. Lancet HIV. 2019 10; 6(10):e667-e679.
    View in: PubMed
    Score: 0.012
  24. Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype. J Periodontol. 1998 Apr; 69(4):428-33.
    View in: PubMed
    Score: 0.011
  25. Moderation of the relationship between Toxoplasma gondii seropositivity and trait impulsivity in younger men by the phenylalanine-tyrosine ratio. Psychiatry Res. 2018 12; 270:992-1000.
    View in: PubMed
    Score: 0.011
  26. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Med. 2018 01; 15(1):e1002493.
    View in: PubMed
    Score: 0.011
  27. GM phenotypes influence the concentrations of the four subclasses of immunoglobulin G in normal human serum. Hum Immunol. 1996 Dec; 51(2):99-102.
    View in: PubMed
    Score: 0.010
  28. Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies. Psychosom Med. 2016 10; 78(8):931-939.
    View in: PubMed
    Score: 0.010
  29. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci Transl Med. 2015 12 23; 7(319):319ra206.
    View in: PubMed
    Score: 0.009
  30. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet. 1995 Oct; 96(4):433-6.
    View in: PubMed
    Score: 0.009
  31. Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults. Clin Exp Immunol. 2015 Dec; 182(3):289-301.
    View in: PubMed
    Score: 0.009
  32. HLA, Gm, and Km polymorphisms and immunity to infectious diseases in South Amerinds. Exp Clin Immunogenet. 1995; 12(3):206-16.
    View in: PubMed
    Score: 0.009
  33. Association of Gm allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J Immunol. 1994 Dec 01; 153(11):5316-20.
    View in: PubMed
    Score: 0.008
  34. Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection. Immunobiology. 2011 Jun; 216(6):686-91.
    View in: PubMed
    Score: 0.006
  35. Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms. Arthritis Rheum. 2009 Oct 15; 61(10):1305-11.
    View in: PubMed
    Score: 0.006
  36. Single nucleotide polymorphism of interleukin-1beta associated with Helicobacter pylori infection in immune thrombocytopenic purpura. Tissue Antigens. 2009 Apr; 73(4):353-7.
    View in: PubMed
    Score: 0.006
  37. Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes. Mol Immunol. 2008 Aug; 45(14):3857-62.
    View in: PubMed
    Score: 0.005
  38. Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2. Hum Immunol. 2008 Mar; 69(3):158-64.
    View in: PubMed
    Score: 0.005
  39. Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. J Rheumatol. 2007 Oct; 34(10):2028-34.
    View in: PubMed
    Score: 0.005
  40. Interaction of KIR genes and G1M immunoglobulin allotypes confer susceptibility to type 2 diabetes in Puerto Rican Americans. Hum Immunol. 2006 Nov; 67(11):907-14.
    View in: PubMed
    Score: 0.005
  41. Immunoglobulin GM and KM genotypes in Korean patients with systemic lupus erythematosus. Rheumatol Int. 2007 Jan; 27(3):219-24.
    View in: PubMed
    Score: 0.005
  42. Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol. 2004 Jun; 65(6):622-31.
    View in: PubMed
    Score: 0.004
  43. Single nucleotide polymorphisms of the inflammatory cytokine genes in adults with chronic immune thrombocytopenic purpura. Br J Haematol. 2004 Mar; 124(6):796-801.
    View in: PubMed
    Score: 0.004
  44. HLA antigens and immunoglobulin allotypes in patients with malignant melanoma. Hum Immunol. 1981 May; 2(3):185-90.
    View in: PubMed
    Score: 0.003
  45. Hyperimmunoglobulinemia E in the absence of atopy and filarial infection: the Huaorani of Ecuador. Allergy Asthma Proc. 2000 Nov-Dec; 21(6):335-41.
    View in: PubMed
    Score: 0.003
  46. Autoantibodies in healthy subjects of different age groups. Mech Ageing Dev. 1979 Jul; 10(6):399-404.
    View in: PubMed
    Score: 0.003
  47. TNFA and TNFB polymorphisms in myasthenia gravis. Arch Neurol. 1999 Apr; 56(4):457-61.
    View in: PubMed
    Score: 0.003
  48. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998 Jun; 41(6):1111-8.
    View in: PubMed
    Score: 0.003
  49. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998 Apr; 41(4):710-9.
    View in: PubMed
    Score: 0.003
  50. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med. 1997 Feb; 45(2):57-68.
    View in: PubMed
    Score: 0.002
  51. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 1997; 26(2):111-6.
    View in: PubMed
    Score: 0.002
  52. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
    View in: PubMed
    Score: 0.002
  53. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma. J Autoimmun. 1990 Jun; 3(3):299-305.
    View in: PubMed
    Score: 0.002
  54. Genetic epidemiology of non-insulin-dependent diabetes mellitus (NIDDM) in north India: distribution of Gm and Km allotypes in 'Punjabis'. Dis Markers. 1990 Mar-Apr; 8(2):59-67.
    View in: PubMed
    Score: 0.002
  55. Familial clustering of scleroderma spectrum disease. Am J Med. 1988 Jun; 84(6):1023-32.
    View in: PubMed
    Score: 0.001
  56. Genes associated with the G2m(23) immunoglobulin allotype regulate the IgG subclass responses to Haemophilus influenzae type b polysaccharide vaccine. J Infect Dis. 1988 Jun; 157(6):1142-9.
    View in: PubMed
    Score: 0.001
  57. Anticentromere antibody and immunoglobulin allotypes in scleroderma. Arch Dermatol. 1985 Mar; 121(3):339-44.
    View in: PubMed
    Score: 0.001
  58. Autoantibodies and immunoglobulin allotypes in healthy North American Blacks of different age groups. Mech Ageing Dev. 1982 Jun; 19(2):103-11.
    View in: PubMed
    Score: 0.001
  59. Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck. Cancer. 1982 May 15; 49(10):2021-4.
    View in: PubMed
    Score: 0.001
  60. Alpha-I-antitrypsin (Pi) phenotypes in Lyon, France: departure from Hardy-Weinberg equilibrium. Clin Genet. 1977 Aug; 12(2):77-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.